- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04683991
Increased Peri-implant Keratinized Mucosal Thickness at Different Operative Times
The Effect of Different Surgical Timing on the Clinical Efficacy of Increasing the Thickness of Keratinized Mucosa Around a Single Posterior Implant: a Prospective, Randomized Controlled Clinical Trial
Keratinized mucosa, which is composed of free gingiva and attached gingiva, is a barrier against bacterial invasion in oral cavity and provides good tissue sealing for periodontal environment. When the keratinized mucosa is insufficient, it is difficult to maintain the long-term stability of the implant, which is not conducive to the peri-implant health. It is generally believed that enough keratinized mucosa width is beneficial to reduce plaque accumulation and reduce the incidence rate of peri-implant diseases. In recent years, clinicians have gradually recognized that the thickness of keratinized mucosa plays an important role in maintaining the peri-implant health. Some researchers found that the thickness of mucosa is very important to maintain the aesthetic effect of implant restoration, and when the thickness of mucosa around the implant is less than 2mm, alveolar bone absorption will occur to maintain a stable biological width. A meta-analysis showed that when the thickness of the keratinized mucosa around the implant was greater than 2mm, the amount of marginal bone loss was significantly reduced (- 0.8mm, P < 0.0001).
It is considered that autogenous soft tissue graft is the most reliable technology to augment keratinized mucosa. Subepithelial connective tissue graft (SCTG) is a mucogingival surgery that transplant autologous free connective tissue under the pedicled semi thick flap to augment keratinized mucosa. It can effectively increase the thickness of soft tissue, cover the exposed implant, and reconstruct the interdental papilla. It is the gold standard for peri-implant soft tissue agumentation. Keratinized mucosal thickening surgery may be done prior to the surgical phase, after the surgical phase, before loading, or even after loading. It is believed that keratinized mucosal thickening at the same time of implantation can effectively reduce the possibility of mucosal recession after implantation, reduce the amount of marginal bone absorption in the process of osseointegration, which is conducive to maintaining the long-term stability of the implant. For the sake of clear clinical vision and convenient operation, clinicians often choose to thicken the keratinized mucosa during the secondary operation, and also obtain good postoperative effect. However, after the completion of the final repair, the keratinized mucosa thickening surgery increases the difficulty of operation and the technical requirements for the operator. In clinical practice, it is rarely selected to perform keratinized mucosal thickening at this time. At present, the effectiveness of timing on the outcome of soft tissue augmentation is still debated, and, most importantly, a direct comparison between simultaneous and staged procedures remains underexplored.
Therefore, this clinical trial is to prospectively compare the clinical efficacy of simultaneous versus delayed timing of soft tissue augmentation by SCTG placement around single implants, by evaluating the peri-implant marginal bone level change and soft tissue change, so as to provide reference for the formulation of clinical treatment plan and the selection of the best operation time.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Weilian Sun, PhD
- Phone Number: 13757119563
- Email: weiliansun@zju.edu.cn
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310009
- Recruiting
- Department of Oral Medicine, the Second Affiliated Hospital, School of Medicine Zhejiang University
-
Contact:
- Weilian Sun
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- No systemic diseases or pregnancy;
- The thickness of keratinized mucosa where the posterior tooth is missing is less than 2 mm;
- Full-mouth plaque score (FMPS) < 20% (measured at four sites per tooth) and bleeding on probing score (BOP%) ≤25% (measured at six sites per tooth);
- Periodontal condition is stable, no probing depths ≥5 mm;
- No previous soft tissue augmentation procedure at experimental site;
- The patient has signed informed consent and accepts the operation of subepithelial connective tissue transplantation.
Exclusion Criteria:
- Patients with uncontrolled hypertension;
- Patients with uncontrolled diabetes;
- Patients with insufficient oral hygiene and Untreated periodontitis;
- Pregnant or lactating women;
- Smoker;
- Patients with long-term (> 6 months) use of glucocorticoids;
- History of malignancy, radiotherapy, or chemotherapy for malignancy within the past 5 years;
- Patients with severe cardiovascular problems;
- Patients with uncontrolled infectious or metabolic diseases;
- Patients with substance abuse.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: treatment group 1
At the same time of implant implantation, autologous tissue is transplanted into the recipient area by using Subepithelial connective tissue graft.
|
A de-epithelialized connective tissue graft is harvested from the homolateral palate and transplanted around the implant.
|
Experimental: treatment group 2
During the second stage operation, autologous tissue is transplanted into the recipient area by using Subepithelial connective tissue graft.
|
A de-epithelialized connective tissue graft is harvested from the homolateral palate and transplanted around the implant.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
peri-implant marginal bone level change
Time Frame: 18 months
|
The bone level of the proximal and distal sites of the implant is measured by oral X-ray parallel projection method.
Compare the image value with the actual value to calculate the actual bone level.
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
peri-implant clinical attachment level change
Time Frame: 18 months
|
The distance between the reference point of impression edge and the bottom of gingival groove around the implant.
|
18 months
|
peri-implant keratinized mucosa width
Time Frame: 18 months
|
keratinized tissue measured as the distance between muco-gingival junction and the gingival margin.
|
18 months
|
peri-implant keratinized mucosa thickness
Time Frame: 18 months
|
gingival thickness measured 1.5 mm coronal to the MGJ using an injection needle, perpendicular to the tissue surface, with a silicon stop over the gingival surface.
|
18 months
|
peri-implant gingival index
Time Frame: 18 months
|
Periodontal probe was used to measure 6 sites on buccal and lingual side each time to observe gingival color, texture and bleeding, and record the scores.
|
18 months
|
peri-implant gingival recession
Time Frame: 18 months
|
The distance between the implant shoulder and the gingival margin of the temporary or final crown was measured with a periodontal probe (only when the implant shoulder was visible).
|
18 months
|
visual analogue scale
Time Frame: 18 months
|
Visual analogous scale ( VAS) suggested by WHO was used to assess.
Analgesia intensity expressed with 0-10, 0 point as without pain completely, 10 points as unbearable pain.
|
18 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Weilian Sun, Second Affiliated Hospital, School of Medicine, Zhejiang University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-782
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peri-Implantitis
-
PolyPid Ltd.MIS Implant Technologies, LtdCompleted
-
University of ManitobaUnknownPeri ImplantitisCanada
-
University of ValenciaCompletedEarly Apical Peri-implantitis
-
Rambam Health Care CampusRecruitingDental Implants,Peri-implantitis,SmokingIsrael
-
Tuğba ŞAHİNCompletedPeri-Implantitis, Peri-implant MucositisTurkey
-
Proed, Torino, ItalyCompleted
-
University of ZagrebNot yet recruitingPeri-implant Mucositis | Peri-Implantitis and Peri-implant Mucositis | Peri-implant Health | Periimplant Diseases | Periimplant Bone Loss
-
National and Kapodistrian University of AthensRecruitingPeri-Implantitis | Peri-Implant HealthGreece
-
Center of Implantology, Oral and Maxillofacial...Recruiting
-
University of BaghdadRecruiting
Clinical Trials on Subepithelial connective tissue graft
-
Texas A&M UniversityLifeNet HealthCompletedGingival Recession
-
Nada Farouk Hasan Abd El-AzizCairo UniversityCompleted
-
Ege UniversityCompleted
-
University of Sao PauloUnknown
-
Pamukkale UniversityCompletedGingival Recession, LocalizedTurkey
-
Postgraduate Institute of Dental Sciences RohtakRecruitingGingival Recession Localized ModerateIndia
-
Cairo UniversityUnknown
-
Maurizio TonettiThe European Research Group on Periodontology (ERGOPerio)CompletedGingival RecessionItaly, Belgium, Germany, Greece, Spain, Switzerland
-
University of Sao PauloCompleted
-
University of IowaBioHorizons, Inc.CompletedTooth Loss | Peri-implant Mucosa DefectUnited States